Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ITI-722: Phase II started

Intra-Cellular began the double-blind Phase II ITI-SMI trial to compare

Read the full 101 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE